Fischer Medical Ventures Ltd
23.87
INR
-1.26
(-5.01%)
ISIN
INE771F01041
Return %
Stock
S&P 500
1Y
-76.09
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
INR
•
in mil. unless spec.Working Capital
INR
•
in mil. unless spec.Growth Rates
INR
•
in mil. unless spec.Quarterly Revenue
INR
•
in mil. unless spec.Quarterly Earnings Per Share
INR
•
in mil. unless spec.Quarterly Dividends Per Share
INR
•
in mil. unless spec.Company Description
- CEO
- Ravindran Govindan
- Full Time Employees
- 19
- Sector
- Process industries
- Industry
- Chemicals: specialty
- Address
- Prestige Palladium Bayan Chennai TN India 600006
- IPO Date
- Jul 10, 2025
- Website
- fischerchemic.com
- Similar Companies
- Business
- Fischer Medical Ventures Ltd is a global MedTech company specializing in the manufacture, distribution, leasing, and maintenance of advanced medical imaging and diagnostic equipment. Its core product portfolio includes Magnetic Resonance Imaging (MRI) systems, AI-powered portable X-ray systems, digital radiography units, and point-of-care diagnostic solutions. The company also offers AI-driven mental health diagnostic platforms, nutraceuticals in collaboration with drug discovery firms, and health technology software through its wholly-owned subsidiary Flynncare Health Innovations Private Limited. Fischer Medical Ventures operates primarily in India with expanding operations in international markets, including Indonesia, where it recently secured a contract for the supply of 250 portable AI-powered X-ray units. Founded and headquartered in Chennai, India, Fischer Medical Ventures leverages strategic partnerships, acquisitions, and investments to drive innovation and growth. Key recent developments include the acquisition of Time Medical International Ventures (India) Private Limited in 2024, expanding its footprint in medical diagnostic imaging; a $6.5 million contract awarded to its subsidiary for AI-enabled portable X-ray supply in Indonesia, supporting government healthcare initiatives; and the launch of the subsidiary Flynncare Health Innovations to develop health technology software solutions. The company also partners with Singapore-based Nanyang Biologics for nutraceutical innovations and has collaborated on mental health AI diagnostics with Wonder Tech. It has introduced the VEGA low-field TOF MRI system for scalable aneurysm screening and secured a digital radiography order from the Tamil Nadu Animal Husbandry Department. These moves underscore Fischer’s strategy to expand its technological capabilities and geographic presence across Asia. Fischer Medical Ventures operates within the medical technology and healthcare sectors, targeting hospitals, clinics, public health agencies, and diagnostic service providers. The company aims to enhance accessibility, affordability, and quality in healthcare delivery through state-of-the-art imaging devices, AI-powered diagnostics, and health IT solutions. Its manufacturing facilities utilize the Andhra Pradesh MedTech Zone (AMTZ) in Vishakhapatnam for advanced MRI production and development of new imaging technologies. Fischer Medical Ventures continues to focus on innovation, digital transformation, and strategic collaborations to capture a growing market share in India and international healthcare markets. The company was previously known as Fischer Chemic Limited and has undergone strategic reorganization to focus on healthcare technology. It reported increased revenues and profitability in recent quarters, indicating successful operational execution and market acceptance of its medical technology products. Its subsidiaries and associated ventures emphasize its intent to become a leading provider of comprehensive medical imaging and diagnostic healthcare solutions regionally and globally. Fischer Medical Ventures Ltd represents a convergent approach to medical technology, combining product manufacturing, digital healthcare solutions, and strategic partnerships to shape the future of healthcare diagnostics and treatment support internationally.